You are here: Home: CCU 1 | 2003: James Cassidy MB, ChB, MSc, MD, FRCP: Select Publications

Select publications regarding oxaliplatin in metastatic colorectal cancer

Borner MM et al. Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol 2002;20(7):1759-66. Abstract

Calvo E et al. Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: A phase II study. Clin Colorectal Cancer 2002;2(2):104-10. Abstract

Hobday TJ et al. Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancer. Clin Colorectal Cancer 2002;2(3):161-9. Abstract

Jordan K et al. Randomized phase II trial of capecitabine plus irinotecan vs capecitabine plus oxaliplatin as first-line therapy in advanced colorectal cancer (ACRC): Results of an interim analysis. Proc ASCO 2002; Abstract 2225.

Kondo Y et al. A multicenter phase II trial of capecitabine (XelodaTM) in previously untreated advanced/metastatic colorectal cancer. Proc ASCO 2002; Abstract 2322.

Kovcin VN et al. First line capecitabine (Xeloda) chemotherapy for metastatic colorectal cancer (MCRC) in patients with liver dysfunction. Proc ASCO 2002; Abstract 2379.

Lersch C et al. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer. Clin Colorectal Cancer 2002;2(1):54-8. Abstract

Recchia F et al. Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapy. Oncol Rep 2003;10(1):65-9. Abstract

Rothenberg ML. Current status of capecitabine in the treatment of colorectal cancer. Oncology (Huntingt) 2002;16(12 Suppl No 14):16-22. Abstract

Shields AF et al. A phase II trial of oxaliplatin and capecitabine in patients with advanced colorectal cancer. Proc ASCO 2002; Abstract 568.

Taberno J et al. Capecitabine and oxaliplatin in combination (Xelox) as first line therapy for patients (pts) with metastatic colorectal cancer (MCRC): Results of an international multicenter phase II trial. Proc ASCO 2002; Abstract 531.

Twelves C. Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer? Oncology (Huntingt) 2002;16(12 Suppl No 14):23-6. Abstract

Wein A et al. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 2003;64(2):131-8. Abstract

Yang TS et al. Biweekly bolus 5-fluorouracil and leucovorin plus oxaliplatin in pretreated patients with advanced colorectal cancer: A dose-finding study. Anticancer Drugs 2003;14(2):145-51. Abstract